Dr Ajay Kirtane (Columbia University Medical Center, New York, NY, US) joins host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) to discuss the findings from the Randomized Sham-controlled RADIANCE-HTN TRIO Trial. RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study TRIO designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.
Recorded remotely from New York and Hamilton, 2021.
Editor: Mirjam Boros